Navigation Links
Delcath Reconfirms Presentation During American Society of Clinical Oncology 2010 Annual Meeting in Chicago
Date:5/19/2010

device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers.  Delcath recently concluded a Phase III metastatic melanoma study and the Company is currently conducting a multi-arm Phase II trial to treat other liver cancers. For more information, please visit the Company's website at www.delcath.com.

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to the acceptability of the Phase III clinical trial data by the FDA, our ability to successfully complete the new drug application, acceptance of the new drug application by the FDA, approval by the FDA or other regulatory authorities of the current or future drug delivery system for the treatment of metastatic melanoma, our ability to successfully complete other clinical trials and secure regulatory approval of our current or future drug-delivery system for the treatment of other liver cancers and other organs and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our fili
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
4. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
5. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. Delcath Systems, Inc. Completes Phase III Study Enrollment
10. Delcath Systems Begins Data Analysis of Phase III Trial
11. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the ... Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... in order to treat dental impairments, for tooth restoration ...
(Date:1/15/2014)... THOUSAND OAKS, Calif. , Jan. 15, 2014 ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ...
(Date:1/15/2014)... 2014  In an unprecedented effort to curb the spread of "superbugs" ... transport vehicles, an advanced and portable UV germicidal lamp manufactured by ... time. In order to prevent EMS paramedics and ... West Palm Beach Fire Rescue is the first ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2
... 19, 2011 Southern Home Medical Equipment, Inc. ... healthcare professionals and equipment to medical institutions, announced ... for specialized solutions for respiratory therapy illnesses, Southern ...  The program provides specialized treatment for Sleep Apnea, ...
... Awarepoint Corporation , the leading provider of ... today announced it has acquired Patient Care ... unites Awarepoint,s unmatched ZigBee based technology platform with ... the industry,s leading all-inclusive enterprise-wide RTLS solution. PCTS ...
Cached Medicine Technology:Southern Home Medical Equipment Launches Respi-Care Respiratory Therapy Program 2Southern Home Medical Equipment Launches Respi-Care Respiratory Therapy Program 3Awarepoint Corporation Announces Acquisition of PCTS 2Awarepoint Corporation Announces Acquisition of PCTS 3Awarepoint Corporation Announces Acquisition of PCTS 4
(Date:4/17/2014)... April 17, 2014 EcoHealth Alliance, a nonprofit ... issues, published a comprehensive review today examining the current ... virus. The review calls for improved global surveillance strategies ... the recent outbreak of Ebola in West Africa that ... countries of Guinea and Liberia. According to the ...
(Date:4/17/2014)... time online has the potential to ward off depression ... to research published online in The Journals ... . In the article " Internet Use and ... A Longitudinal Analysis ," the authors report that Internet ... 33 percent among their study sample. , Late-life ...
(Date:4/17/2014)... 2014) Population Council scientists and their partners have found ... can prevent the transmission of multiple sexually transmitted infections ... HIV, herpes simplex virus 2 (HSV-2), and human papillomavirus ... that the gel is effective against multiple strains of ... vagina against all three viruses of at least eight ...
(Date:4/17/2014)... Meaningful long-term survival is possible for selected patients ... treated with cytoreductive surgery with Hyperthermic IntraPeritoneal Chemotherapy, ... physicians at Wake Forest Baptist Medical Center. , ... experience with cytoreductive surgery and HIPEC, said lead ... 20 years, worth of patient data shows that ...
(Date:4/17/2014)... world is less than 40 years away from a ... and governments, according to a top scientist at the ... in human history, food production will be limited on ... and energy," said Dr. Fred Davies, senior science advisor ... could become as politically destabilizing by 2050 as energy ...
Breaking Medicine News(10 mins):Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Internet use may cut retirees' depression 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2Health News:20 years of data shows treatment technique improvement for advanced abdominal cancer 2Health News:Food shortages could be most critical world issue by mid-century 2
... study published in the July issue of the Journal ... for substance abuse and mental health in primary care ... This may be a missed opportunity to help people ... fraction of whom currently receive treatment. ,Lead author ...
... neuroscientist reports that the cutting-edge research study of human ... on several fronts particularly how the transplanted ... ,Paul R. Sanberg, DSc, PhD, Distinguished Professor of ... Brain Repair at USF Health, wrote the commentary Neural ...
... variant ,A group of research scientist from ... discovered a gene variant which augments the possibility of ... DOI 10.1002/hep.21847). Probably one on ten Europeans has this ... developing a gallstone in their life time goes up ...
... increased from 13 percent to 32 percent between the ... Hopkins Bloomberg School of Public Health Center for ... increased at an average rate of 0.30.8 percentage points ... , Some minority and low socioeconomic status ...
... selective of its reaction to a particular variety of sugar ... to Biology textbooks neutrophils are regarded as mindless killers. White ... are the policeman guarding our internal body. They protect our ... fungi by spotting and wiping out any intruder that invades ...
... Dana-Farber Cancer Institute have identified a long-sought "master switch" in ... of adipose tissue that generates heat and counters obesity caused ... PhD, suggests in the July issue of Cell Metabolism that ... new strategy for treating overweight and obesity. The investigators said ...
Cached Medicine News:Health News:Screening for Behavioral Health 2Health News:Stem Cells Research in Parkinsons Disease 2Health News:Gallstone Gene Discovered by Research Team 2Health News:U.S Shows Increased Obesity Rate 2Health News:WBC Selective About Sugar 2Health News:Scientists Identified Obesity Control Switch 2
CleanBox DNA workstation with two 254nm UV lambs & 12-hr timer, 90cm (36-inch)width, single door, 115V (w/crating)...
... for low to medium throughput reading of entire ... one to three racks and reads in approximately ... exported via text files and a list of ... with other programs. System includes a USB HP ...
... Stainless steel workbench top ... is adjustable from 25"-34". Available ... configurations. Accessories include shelves, drawers, ... Terra is an expert in ...
... frames ensure cleanroom compatibility ... and chemical resistance. These ... user-friendly pnuematic controls for ... footring standard. Five leg ...
Medicine Products: